What is he best known for?
The fields of study he is best known for:
- Gene
- Neuron
- Neurotransmitter
His scientific interests lie mostly in Receptor, Cell biology, Biochemistry, Homomeric and Protein subunit.
In his works, Philippe Séguéla conducts interdisciplinary research on Receptor and Trigeminovascular system.
His Cell biology research includes elements of D2-like receptor and Cys-loop receptors.
His Biochemistry research incorporates themes from Glutaraldehyde and Antiserum.
His work deals with themes such as Xenopus and Ion channel, which intersect with Protein subunit.
In his study, Neuroscience is inextricably linked to TRPV1, which falls within the broad field of Endocrinology.
His most cited work include:
- Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium (1332 citations)
- International Union of Pharmacology. XXIV. Current Status of the Nomenclature and Properties of P2X Receptors and Their Subunits (577 citations)
- Antibodies against gamma-aminobutyric acid: specificity studies and immunocytochemical results. (305 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Neuroscience, Receptor, Cell biology, Biochemistry and Homomeric.
His Neuroscience research incorporates elements of Nociceptor and Nociception.
His Receptor study incorporates themes from Extracellular and Pharmacology.
The concepts of his Cell biology study are interwoven with issues in Endocrinology, Xenopus, Microglia, Internal medicine and Metabotropic receptor.
His studies examine the connections between Xenopus and genetics, as well as such issues in Protein subunit, with regards to Ion channel, Molecular biology and Peptide sequence.
His Biochemistry study deals with Biophysics intersecting with Reversal potential.
He most often published in these fields:
- Neuroscience (40.78%)
- Receptor (34.95%)
- Cell biology (33.01%)
What were the highlights of his more recent work (between 2011-2021)?
- Neuroscience (40.78%)
- Receptor (34.95%)
- Cell biology (33.01%)
In recent papers he was focusing on the following fields of study:
Philippe Séguéla mainly investigates Neuroscience, Receptor, Cell biology, Optogenetics and Nociceptor.
His Neuroscience study frequently draws parallels with other fields, such as Nociception.
His study in the fields of Purinergic receptor under the domain of Receptor overlaps with other disciplines such as P2RX7.
The study incorporates disciplines such as In vitro, Neurotrophin, Ion channel and Metabotropic receptor in addition to Cell biology.
Homomeric is closely connected to Membrane potential in his research, which is encompassed under the umbrella topic of Ion channel.
His biological study spans a wide range of topics, including Peripheral and Opioid.
Between 2011 and 2021, his most popular works were:
- Remote Optogenetic Activation and Sensitization of Pain Pathways in Freely Moving Mice (114 citations)
- P2Y12 expression and function in alternatively activated human microglia (92 citations)
- Optogenetic Silencing of Nav1.8-Positive Afferents Alleviates Inflammatory and Neuropathic Pain. (63 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Neuron
- Neurotransmitter
Neuroscience, Nociceptor, Nociception, Calcium and Pharmacology are his primary areas of study.
In the field of Neuroscience, his study on Neuropathic pain and Electrophysiology overlaps with subjects such as Prefrontal cortex.
His studies deal with areas such as Optogenetics and Channelrhodopsin as well as Nociceptor.
His Cell biology research extends to the thematically linked field of Calcium.
His research in Cell biology tackles topics such as Antagonism which are related to areas like Microglia and Neuroinflammation.
His Pharmacology study combines topics in areas such as Calcium in biology and Receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
